Written Question · S3W-04180 · Session 3
Further to the answer to question S2W-31920 by Mr Andy Kerr on 27 February 2007, whether, following the approval of Lucentis® (ranibizumab)…
The question
To ask the Scottish Executive, further to the answer to question S2W-31920 by Mr Andy Kerr on 27 February 2007, whether, following the approval of Lucentis® (ranibizumab) on 22 January 2007 by the European Medicines Evaluation Agency, the Scottish Medicines Consortium has made a recommendation regarding the use of this therapy.
The answer
The ScottishMedicines Consortium recommended Lucentis for use in NHS Scotland on 11 June 2007. Further information is available at: www.scottishmedicines.org.
In the Official Report
No contribution in the Official Report cites S3W-04180 by reference.